Up-regulation of alveolar macrophage matrix metalloproteinases in HIV1 + smokers with early emphysema

Robert J. Kaner, Francisco Santiago, Ronald Crystal

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

HIV1+ smokers develop emphysema at an earlier age and with a higher incidence than HIV1- smokers. Since human alveolar macrophages (AMs) are capable of producing proteases that degrade extracellular matrix components, we hypothesized that up-regulation of AM matrix metalloproteinases may be associated with the emphysema of HIV1+ smokers. Microarray analysis was used to screen which matrix metalloproteinases (MMPs) genes were expressed by AM of HIV1+ smokers with early emphysema. For each of the MMP genes expressed (MMP-1, -2, -7, -9, -10, -12 and -14), TaqMan PCR was used to quantify the relative expression in AM from four groups of individuals: HIV1- healthy nonsmokers, HIV1- healthy smokers, HIV1 - smokers with early emphysema, and HIV1+ smokers with early emphysema. While AM gene expression of MMPs was higher in HIV1- individuals with emphysema in comparison with HIV1- healthy smokers, for the majority of the MMPs (-1, -7, -9, and -12), AM expression from HIV1- smokers with early emphysema was significantly higher than in HIV1- smokers with early emphysema. HIV1+ individuals with early emphysema also had higher levels of epithelial lining fluid (ELF) MMPs (-2, -7, -9, and -12) than the 3 HIV1- groups. ELF MMP (-2,-7,-9, and -12) levels were similar in HIV1+ nonsmokers compared with HIV1 - nonsmokers. Interestingly, the active forms of MMP-2, -9, and -12 were exclusively detected in ELF from HIV1+ individuals with early emphysema. Since the activities of the up-regulated AM MMPs include collagenases, gelatinases, matrilysins, and elastase, these data suggest that up-regulated AM MMP genes and activation of MMP proteins may contribute to the emphysema of HIV1+ individuals who smoke.

Original languageEnglish
Pages (from-to)913-922
Number of pages10
JournalJournal of Leukocyte Biology
Volume86
Issue number4
DOIs
Publication statusPublished - 1 Oct 2009
Externally publishedYes

Fingerprint

Emphysema
Alveolar Macrophages
Matrix Metalloproteinases
Up-Regulation
Matrix Metalloproteinase 7
Matrix Metalloproteinase 2
Matrix Metalloproteinase 1
Gelatinases
Pancreatic Elastase
Matrix Metalloproteinase 9
Collagenases
Microarray Analysis
Smoke
Transcriptional Activation
Genes
Extracellular Matrix
Peptide Hydrolases
Gene Expression
Polymerase Chain Reaction

Keywords

  • Human
  • Lung
  • Lung disease
  • Pathogenesis
  • Protease

ASJC Scopus subject areas

  • Immunology
  • Cell Biology

Cite this

Up-regulation of alveolar macrophage matrix metalloproteinases in HIV1 + smokers with early emphysema. / Kaner, Robert J.; Santiago, Francisco; Crystal, Ronald.

In: Journal of Leukocyte Biology, Vol. 86, No. 4, 01.10.2009, p. 913-922.

Research output: Contribution to journalArticle

@article{e9e26235e4334afba02c0906d33e4a0e,
title = "Up-regulation of alveolar macrophage matrix metalloproteinases in HIV1 + smokers with early emphysema",
abstract = "HIV1+ smokers develop emphysema at an earlier age and with a higher incidence than HIV1- smokers. Since human alveolar macrophages (AMs) are capable of producing proteases that degrade extracellular matrix components, we hypothesized that up-regulation of AM matrix metalloproteinases may be associated with the emphysema of HIV1+ smokers. Microarray analysis was used to screen which matrix metalloproteinases (MMPs) genes were expressed by AM of HIV1+ smokers with early emphysema. For each of the MMP genes expressed (MMP-1, -2, -7, -9, -10, -12 and -14), TaqMan PCR was used to quantify the relative expression in AM from four groups of individuals: HIV1- healthy nonsmokers, HIV1- healthy smokers, HIV1 - smokers with early emphysema, and HIV1+ smokers with early emphysema. While AM gene expression of MMPs was higher in HIV1- individuals with emphysema in comparison with HIV1- healthy smokers, for the majority of the MMPs (-1, -7, -9, and -12), AM expression from HIV1- smokers with early emphysema was significantly higher than in HIV1- smokers with early emphysema. HIV1+ individuals with early emphysema also had higher levels of epithelial lining fluid (ELF) MMPs (-2, -7, -9, and -12) than the 3 HIV1- groups. ELF MMP (-2,-7,-9, and -12) levels were similar in HIV1+ nonsmokers compared with HIV1 - nonsmokers. Interestingly, the active forms of MMP-2, -9, and -12 were exclusively detected in ELF from HIV1+ individuals with early emphysema. Since the activities of the up-regulated AM MMPs include collagenases, gelatinases, matrilysins, and elastase, these data suggest that up-regulated AM MMP genes and activation of MMP proteins may contribute to the emphysema of HIV1+ individuals who smoke.",
keywords = "Human, Lung, Lung disease, Pathogenesis, Protease",
author = "Kaner, {Robert J.} and Francisco Santiago and Ronald Crystal",
year = "2009",
month = "10",
day = "1",
doi = "10.1189/jlb.0408240",
language = "English",
volume = "86",
pages = "913--922",
journal = "Journal of Leukocyte Biology",
issn = "0741-5400",
publisher = "FASEB",
number = "4",

}

TY - JOUR

T1 - Up-regulation of alveolar macrophage matrix metalloproteinases in HIV1 + smokers with early emphysema

AU - Kaner, Robert J.

AU - Santiago, Francisco

AU - Crystal, Ronald

PY - 2009/10/1

Y1 - 2009/10/1

N2 - HIV1+ smokers develop emphysema at an earlier age and with a higher incidence than HIV1- smokers. Since human alveolar macrophages (AMs) are capable of producing proteases that degrade extracellular matrix components, we hypothesized that up-regulation of AM matrix metalloproteinases may be associated with the emphysema of HIV1+ smokers. Microarray analysis was used to screen which matrix metalloproteinases (MMPs) genes were expressed by AM of HIV1+ smokers with early emphysema. For each of the MMP genes expressed (MMP-1, -2, -7, -9, -10, -12 and -14), TaqMan PCR was used to quantify the relative expression in AM from four groups of individuals: HIV1- healthy nonsmokers, HIV1- healthy smokers, HIV1 - smokers with early emphysema, and HIV1+ smokers with early emphysema. While AM gene expression of MMPs was higher in HIV1- individuals with emphysema in comparison with HIV1- healthy smokers, for the majority of the MMPs (-1, -7, -9, and -12), AM expression from HIV1- smokers with early emphysema was significantly higher than in HIV1- smokers with early emphysema. HIV1+ individuals with early emphysema also had higher levels of epithelial lining fluid (ELF) MMPs (-2, -7, -9, and -12) than the 3 HIV1- groups. ELF MMP (-2,-7,-9, and -12) levels were similar in HIV1+ nonsmokers compared with HIV1 - nonsmokers. Interestingly, the active forms of MMP-2, -9, and -12 were exclusively detected in ELF from HIV1+ individuals with early emphysema. Since the activities of the up-regulated AM MMPs include collagenases, gelatinases, matrilysins, and elastase, these data suggest that up-regulated AM MMP genes and activation of MMP proteins may contribute to the emphysema of HIV1+ individuals who smoke.

AB - HIV1+ smokers develop emphysema at an earlier age and with a higher incidence than HIV1- smokers. Since human alveolar macrophages (AMs) are capable of producing proteases that degrade extracellular matrix components, we hypothesized that up-regulation of AM matrix metalloproteinases may be associated with the emphysema of HIV1+ smokers. Microarray analysis was used to screen which matrix metalloproteinases (MMPs) genes were expressed by AM of HIV1+ smokers with early emphysema. For each of the MMP genes expressed (MMP-1, -2, -7, -9, -10, -12 and -14), TaqMan PCR was used to quantify the relative expression in AM from four groups of individuals: HIV1- healthy nonsmokers, HIV1- healthy smokers, HIV1 - smokers with early emphysema, and HIV1+ smokers with early emphysema. While AM gene expression of MMPs was higher in HIV1- individuals with emphysema in comparison with HIV1- healthy smokers, for the majority of the MMPs (-1, -7, -9, and -12), AM expression from HIV1- smokers with early emphysema was significantly higher than in HIV1- smokers with early emphysema. HIV1+ individuals with early emphysema also had higher levels of epithelial lining fluid (ELF) MMPs (-2, -7, -9, and -12) than the 3 HIV1- groups. ELF MMP (-2,-7,-9, and -12) levels were similar in HIV1+ nonsmokers compared with HIV1 - nonsmokers. Interestingly, the active forms of MMP-2, -9, and -12 were exclusively detected in ELF from HIV1+ individuals with early emphysema. Since the activities of the up-regulated AM MMPs include collagenases, gelatinases, matrilysins, and elastase, these data suggest that up-regulated AM MMP genes and activation of MMP proteins may contribute to the emphysema of HIV1+ individuals who smoke.

KW - Human

KW - Lung

KW - Lung disease

KW - Pathogenesis

KW - Protease

UR - http://www.scopus.com/inward/record.url?scp=70349651560&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349651560&partnerID=8YFLogxK

U2 - 10.1189/jlb.0408240

DO - 10.1189/jlb.0408240

M3 - Article

VL - 86

SP - 913

EP - 922

JO - Journal of Leukocyte Biology

JF - Journal of Leukocyte Biology

SN - 0741-5400

IS - 4

ER -